Michelle Arbus Interview with Business of Cannabis for Green + Silver
Michelle Arbus joined Business of Cannabis to talk about how the data that she will be presenting identifies trends among older cannabis users and what that means for medical cannabis patients.
Michelle and Noah Featured on Humble & Fred Radio
Michelle and Noah Featured on Humble & Fred Radio Newest additions to the Strainprint team- Michelle and Noah joined Humble & Fred to talk all things cannabis! Follow our Strainprint Features Playlist on YouTube to stay tuned in and up to date on what we’re doing at Strainprint.
Strainprint Featured In The Green Market Report
Strainprint Featured In The Green Market Report – Big Data Opens A New Path for Cannabis Patients Strainprint is leading the way in the cannabis industry with its rich and robust medical patient data and sophisticated Business Intelligence solutions. With a vision to advance the scientific understanding of cannabis and its legitimization as a therapy […]
Strainprint on Humble & Fred Radio Show
Have a listen to our latest guest appearance, Ashleigh Brown Community Manager & Patient Liaison for Strainprint, & Founder of SheCann on Humble & Fred Radio
Strainprint Technologies Ltd. & Emblem Cannabis on Humble & Fred Radio
On Wednesday, July 11th, 2018 Strainprint President & CTO, David Berg, and COO of Emblem Cannabis Corp, Adam Saperia had the opportunity to appear on the Humble & Fred Radio show where they talked about the benefits of medical cannabis, patient tracking and how data is helping to shape the future of the cannabis industry.
Strainprint Participates in CannabisFest
On July 10th, 2018 Strainprint had the opportunity to participate in CannabisFest where our Founder, Stephanie Karasick participated in an AMA focused on how Entrepreneurs can prepare for legalization. https://betakit.com/cannabisfest-explores-how-entrepreneurs-can-prepare-for-legalization/
Strainprint™ Closes USD $3 Million (Cdn.$3.8M) Series A Funding
TORONTO, May 8, 2018 /PRNewswire/ – StrainprintTM Technologies — the leader in cannabis data and analytics is pleased to announce the closing of a USD $3 Million (Cdn.$3.8 Million) non-brokered, Series A private placement. The round was led by strategic industry investor, Cesare Fazari, Chairman of Molecular Science Corp and seed investor of leading cannabis companies, Ample Organics and Hydropothecary. Mr. Fazari […]
Strainprint President & CTO, David Berg Featured in Cannabis Investing News
The legalization of cannabis has allowed researchers to begin investigating the drug at more in-depth levels than before. With the current state of cannabis working towards legalization across the globe, new channels of research are opening up across the board as an effort to rapidly catch up with a market ready to consume a product […]
Strainprint Featured in The Leaf Cannabis News: Finding the right stuff Cannabis-tech firms' experience-based apps help medical and recreational users through the confusing maze of strains and their effects
03/15/2018 – Strainprint was recently featured In The Leaf Cannabis News Where our President, David Berg discussed Cannabis Tech-Apps. – Berg says Strainprint has “over six million data points collected and over 300,000 validated sessions,” describing that database as “the largest longitudinal study on cannabis in the world.” He says that information can address the dearth of […]